首页> 美国卫生研究院文献>Hematology Transfusion and Cell Therapy >Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia
【2h】

Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia

机译:慢性淋巴细胞性白血病的诊断和治疗:巴西慢性淋巴细胞性白血病小组的建议

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic lymphocytic leukemia is characterized by clonal proliferation and progressive accumulation of B-cell lymphocytes that typically express CD19+, CD5+ and CD23+. The lymphocytes usually infiltrate the bone marrow, peripheral blood, lymph nodes, and spleen. The diagnosis is established by immunophenotyping circulating B-lymphocytes, and prognosis is defined by two staging systems (Rai and Binet) established by physical examination and blood counts, as well as by several biological and genetic markers. In this update, we present the recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia for the diagnosis and treatment of chronic lymphocytic leukemia. The following recommendations are based on an extensive literature review with the aim of contributing to more uniform patient care in Brazil and possibly in other countries with a similar social–economic profile.
机译:慢性淋巴细胞性白血病的特征是通常表达CD19 + ,CD5 + 和CD23 + 的B细胞淋巴细胞的克隆增殖和进行性积累。淋巴细胞通常会渗入骨髓,外周血,淋巴结和脾脏。诊断是通过对循环中的B淋巴细胞进行免疫分型来确定的,预后由两种分期系统(Rai和Binet)定义,这些系统是通过体格检查和血细胞计数以及几种生物学和遗传标记建立的。在此更新中,我们提出了巴西慢性淋巴细胞性白血病小组对慢性淋巴细胞性白血病的诊断和治疗的建议。以下建议基于广泛的文献综述,旨在为巴西以及可能在具有相似社会经济特征的其他国家/地区提供更统一的患者护理。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号